Johnson & Johnson (JNJ) returns

Pharmaceuticals · NYSE · Health Care

$273.20 -0.73% Close Oct 30, 2026 Live

Johnson & Johnson returns over 10 years

$1,000 invested in Johnson & Johnson ten years ago was worth $3,108 at the close on October 30, 2026, with dividends reinvested: an average return of 12.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

JNJ, $10,000 investedS&P 500 (SPY)
$10,000$20,000$30,000$40,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +3.2% — $1,032 -0.9%
3 months +7.3% — $1,073 +2.1%
Year to date +34.1% — $1,341 +11.7%
1 year +47.8% — $1,478 +12.4%
3 years +102.3% +26.5% $2,023 +88.5%
5 years +92.8% +14.0% $1,928 +76.0%
10 years +210.8% +12.0% $3,108 +316.6%

Johnson & Johnson return by calendar year

YearJNJS&P 500 (SPY)Difference
2026 to date +34.1% +11.7% +22.4%
2025 +47.5% +17.7% +29.7%
2024 -4.8% +24.9% -29.7%
2023 -8.6% +26.2% -34.8%
2022 +6.0% -18.2% +24.1%
2021 +11.4% +28.7% -17.3%
2020 +10.9% +18.4% -7.5%
2019 +16.2% +31.2% -15.0%
2018 -5.1% -4.6% -0.6%
2017 +24.4% +21.7% +2.7%
2016 +15.3% +12.0% +3.3%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: JNJ financials · JNJ valuation

No forecast, no recommendation. This page describes Johnson & Johnson from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.